Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) submission for povetacicept, an ...

The ELIMINATE trial: A phase II/III randomized trial evaluating omission of radiotherapy to regional lymphatics in pN0/N1 neck for oral cavity carcinomas. Background: Postoperative radiotherapy (PORT) ...

June 22 (Reuters) - Regenxbio (RGNX.O), opens new tab said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support an accelerated approval application, ...

US FDA Reverses Course on Regenxbio's Rare-Disease Gene Therapy, Backs Accelerated Approval Bid By Siddhi Mahatole June 22 (Reuters) - Regenxbio said on Monday ⁠the ⁠U.S. FDA has indicated that ...

From Left to Right: 1. Prof. Paulo De Souza, Deputy Vice Chancellor, ECU 2. Prof. Clare Pollock, Vice Chancellor ECU 3. Rhodri Biggs, Western Australian State Government 4. Caitlin Collins MLA, ...

A Rocket Pharmaceuticals gene therapy has landed a long-awaited FDA approval, bringing a new treatment option to patients with a certain inherited immunodeficiency so severe that many babies do not ...

The U.S., Israel and Argentina on Wednesday voted against a United Nations resolution led by Ghana to label the international slave trade as the “gravest crime against humanity” and call for ...

YouTube has increased its thumbnail upload limit from 2MB to 50MB to improve the user experience on smart TVs and streaming devices. This allows creators to provide high-quality visuals on big screens ...

The FDA has accepted a biologics license application from Inovio for a potential treatment for adults with recurrent respiratory papillomatosis. Although the application was filed under the ...

Microsoft is rolling out hardware-accelerated BitLocker in Windows 11 to address growing performance and security concerns by leveraging the capabilities of system-on-a-chip and CPU. BitLocker is the ...